TY - JOUR
AU - 
TI - Nimotuzumab Induces NK Cell Activation, Cytotoxicity, Dendritic Cell Maturation and Expansion of EGFR-Specific T Cells in Head and Neck Cancer Patients
JF - Frontiers in Pharmacology
DO - 10.3389/fphar.2017.00382
DA - 2017-06-19
UR - https://www.deepdyve.com/lp/unpaywall/nimotuzumab-induces-nk-cell-activation-cytotoxicity-dendritic-cell-1AIpSFCVe9
DP - DeepDyve
ER -